Lung cancer vaccine that uses mRNA technology is in human trial phase

Several countries are hosting studies of an mRNA vaccine treatment for lung cancer, which kills 1.8 million people every year. Scientists hope that the principles used to develop a COVID-19 vaccine could also be applied to various cancers. Tony de Fougerolles explains the concept and the promise offered by the treatment that’s being studied.

Tell us about your experience accessing The World

We want to hear your feedback so we can keep improving our website, theworld.org. Please fill out this quick survey and let us know your thoughts (your answers will be anonymous). Thanks for your time!